St. Luke's Cancer Institute
Locations
Transplant Summary
Overview
The St. Luke's Cancer Institute – Center for Blood Cancer Therapy offers comprehensive care and cellular therapy for patients with leukemia, lymphoma, multiple myeloma, myelodysplastic disorders, and other blood cancers. We're proud to be Idaho's only blood and marrow transplant program, offering autologous and allogeneic bone marrow/stem cell transplants and CART therapies at St. Luke’s Boise. Our dedicated team focuses on your quality of life while providing novel therapies, access to clinical trials, and supportive care, close to home.This center has been performing allogeneic transplants since 2018 and has been an NMDP transplant center since May 2020.
Attending physicians
Adult - Zachary Benson, William Kreisle, Travis WilliamsTransplants performed
Marrow/PBSC onlyCord blood transplants
Not performedOther programs and services
Our program offers full support from an interdisciplinary team specialized in the care of patient under going transplant. This team includes providers, social workers, patient financial advocates, pharmacists, and nurse navigators to help guide patients through the transplant process. Local discounted housing may be available in coordination with our social work team.Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 27 patients.The actual 1-year survival of these patients is 66.7%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 62.2% and 92.2%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
79
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow1PBSC10Cord blood0Total11Unrelated donorMarrow0PBSC19Cord blood0Total19Total allogeneicMarrow1PBSC29Cord blood0Total30AutologousMarrowBoth marrow & PBSC 49PBSC—Cord blood—Total49Total combinedMarrowBoth marrow & PBSC 79PBSC—Cord blood0Total79Total pediatric transplants
7
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow0PBSC0Cord blood0Total0Unrelated donorMarrow0PBSC0Cord blood0Total0Total allogeneicMarrow0PBSC0Cord blood0Total0AutologousMarrowBoth marrow & PBSC 7PBSC—Cord blood—Total7Total combinedMarrowBoth marrow & PBSC 7PBSC—Cord blood0Total7All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-18019-44145-64765+3Total11Unrelated 0-18019-44345-641065+6Total19Autologous 0-18819-44645-642265+20Total56Total 0-18819-441045-643965+29Total86Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
St. Luke's Cancer Institute
100 E Idaho Boise, ID 83712 Phone:208-381-5032 Physician Referrals:208-381-2711 Email:singel@slhs.org For more information about this program: https://www.stlukesonline.org/ (Opens in a new tab)Staff
Adult Program Director:Travis G Williams, DOPediatric Program Director:Nate Meeker, MDAdult Program Coordinator:Ali Gerber, RNPediatric Program Coordinator:Ali Gerber, RNMedical Specialties in Program
Allergy/immunology, cardiology, complementary and alternative medicine, dermatology, endocrinology, gastroenterology, general surgery, gynecology, hematology, hepatology, infectious disease, nephrology, neurology, oncology, ophthalmology/optometry, orthopedics, palliative care, psychiatry/psychology, pulmonology, rheumatology, telemedicine, urology.Medical Services Offered
Chronic GVHD management, fertility counseling, reproductive health, financial counseling, genetic counseling, nutrition/dietetics, occupational therapy, pain management, physical therapy and rehabilitation, sexual health, social services, vaccinations.Telemedicine services are available.Patient Eligibility
Children- Autologous transplant recipients
- Patients who were transplanted as a child at this center with no upper age limit
- Does accept patients who were transplanted at another hospital